19.5
View the full transcript and gain access to JoVE Core videos
Q1: What role do hemagglutinin and neuraminidase play in influenza infection?
Hemagglutinin and neuraminidase are two essential glycoproteins on the influenza A viral surface. Hemagglutinin binds to sialic acid receptors on host cells, enabling viral entry. Neuraminidase cleaves sialic acid residues on the host cell membrane, allowing newly formed virions to detach and spread infection to neighboring cells.
Q2: How do neuraminidase inhibitors prevent viral release?
Neuraminidase inhibitors are structural analogs of sialic acid that block neuraminidase activity by binding to its active site. When neuraminidase cannot function, it cannot cleave sialic acid residues on the host cell membrane. As a result, newly formed virions remain tethered to the host cell surface, preventing further spread of infection.
Q3: Why does the influenza virus initially remain attached to the host cell after budding?
After new virions bud from the host cell membrane, they initially remain attached because hemagglutinin on the viral surface continues to bind to sialic acid residues on the host cell membrane. This attachment must be broken for the virus to spread. Neuraminidase cleaves these sialic acid residues, liberating the virions and enabling infection of neighboring cells.
Q4: What happens to viral proteins after they are synthesized inside the host cell?
Newly synthesized viral proteins, including hemagglutinin and neuraminidase, are transported to the host cell membrane where they coalesce to form progeny virions. These viral particles bud from the plasma membrane, acquiring a lipid envelope embedded with these glycoproteins. This assembly process is essential for creating infectious viral particles.
Q5: How does the influenza virus use the host cell's machinery for replication?
After viral entry, the viral RNA is transported to the nucleus where it is transcribed into positive-sense mRNA by the viral RNA-dependent RNA polymerase. These viral mRNAs then hijack the host's translational machinery to produce viral proteins needed for replication and assembly. This dependence on host cell processes makes the virus vulnerable to antiviral interventions.
Q6: What is the mechanism of action for drugs like oseltamivir?
Oseltamivir and other neuraminidase inhibitors function as competitive inhibitors by mimicking sialic acid, the natural substrate for neuraminidase. These drugs bind to the active site of neuraminidase, obstructing its enzymatic function. This prevents the cleavage of sialic acid residues, keeping virions anchored to the host cell and curtailing viral propagation.
Q7: Why is viral release critical for influenza pathogenicity?
Viral release from an infected cell is crucial for the spread of infection to neighboring cells. Without efficient release, the virus cannot propagate and establish systemic infection. Neuraminidase's ability to cleave sialic acid residues is essential for liberating virions from the host cell surface, making this step fundamental to influenza's pathogenic potential.